<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>272395</rcn>
  <id>101213464</id>
  <acronym>VIVID</acronym>
  <teaser>VIVID is a project on the Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics. Optimising cancer treatment is a challenge, especially with combination therapies and patient variability. The ability to study cell migration in a quantitative and non-invasive...</teaser>
  <objective>VIVID is a project on the Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics. 

Optimising cancer treatment is a challenge, especially with combination therapies and patient variability. The ability to study cell migration in a quantitative and non-invasive manner in vivo, of endogenous cancer-fighting immune cells and administered therapeutic cells is essential for biomarker-driven and personalised clinical trials. Our imaging agent, BEACONs, allow for multimodal, quantitative imaging of cell populations; here with quantitative 19F MRI and fluorescence. 

This project will demonstrate and validate the feasibility of cell tracking using multimodal imaging and increase the maturity of BEACONs (to TRL 5-6) through a first-in-man clinical trial in current cancer standard of care.

Our specific objectives are to 1) Set up a clinical trial of interest to large pharma, here the imaging of labelled immune cells in a neoadjuvant setting; 2) Build a business plan and create a spin-off; 3) Ensure that any new IP is protected; 4) Perform outreach towards patients and end-users.

The potential societal impact of using BEACONs includes being able to assess and adapt complex therapies in major diseases such as cancer organ transplants, allowing a more targeted treatment and reducing patient burden such as negative side effects of ineffective treatment. The economic benefit of using BEACONs is large, while also reducing animal use, and enabling early assessment of cell therapies and cancer therapies.

VIVID allows the application of our technology in a new field -that of personalisation of cancer therapy- aside from cell therapies, increasing our potential customer base (oncology drug market expected $285B in 2023).</objective>
  <title>Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>2443726</ecMaxContribution>
  <startDate>2025-07-01</startDate>
  <endDate>2028-06-30</endDate>
  <ecSignatureDate>2025-05-21</ecSignatureDate>
  <duration>36</duration>
  <status>SIGNED</status>
  <keywords>Imaging agent,  non-invasive cell tracking,  19F MRI,  quantitative fluorescence endoscopy,  cell monitoring,  imaging product package</keywords>
  <identifiers>
    <grantDoi>10.3030/101213464</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-05-23 14:53:23</sourceUpdateDate>
  <contentCreationDate>2025-05-26 12:51:23</contentCreationDate>
  <contentUpdateDate>2025-05-23 14:53:23</contentUpdateDate>
  <lastUpdateDate>2025-11-03 09:43:24</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>459688</rcn>
        <id>459688-real-time-immune-cell-imaging-in-cancer-patients</id>
        <title>Real-time immune cell imaging in cancer patients</title>
        <contentUpdateDate>2025-10-08 16:28:50</contentUpdateDate>
        <relations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode>/Health</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>56677</rcn>
        <title>HORIZON-EIC-2024-TRANSITION-01</title>
        <identifier>HORIZON-EIC-2024-TRANSITION-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56677</rcn>
        <title>HORIZON-EIC-2024-TRANSITION-01</title>
        <identifier>HORIZON-EIC-2024-TRANSITION-01</identifier>
      </call>
      <organization netEcContribution="380812.5" totalCost="0" source="corda" order="4" ecContribution="380812.5" terminated="false" sme="true" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1952607</rcn>
        <id>911296668</id>
        <vatNumber>DE309707835</vatNumber>
        <legalName>MYBIOTECH GMBH</legalName>
        <shortName>MyB</shortName>
        <address>
          <street>INDUSTRIESTRASSE 1B</street>
          <city>UBERHERRN</city>
          <postalCode>66802</postalCode>
          <country>DE</country>
          <geolocation>51.0834196,10.4234469</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Saarlouis</name>
              <rcn>221822980</rcn>
              <nutsCode>DEC04</nutsCode>
              <parents>
                <region>
                  <name>Saarland</name>
                  <rcn>221823016</rcn>
                  <nutsCode>DEC0</nutsCode>
                  <parents>
                    <region>
                      <name>Saarland</name>
                      <rcn>221825576</rcn>
                      <nutsCode>DEC</nutsCode>
                      <parents>
                        <region>
                          <name>Germany</name>
                          <rcn>221940264</rcn>
                          <nutsCode>DE</nutsCode>
                          <euCode>DE</euCode>
                          <isoCode>DE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Germany</name>
              <rcn>221940264</rcn>
              <nutsCode>DE</nutsCode>
              <euCode>DE</euCode>
              <isoCode>DE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="1217250" totalCost="0" source="corda" order="2" ecContribution="1217250" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1908881</rcn>
        <id>999914801</id>
        <vatNumber>NL800866393B01</vatNumber>
        <legalName>ACADEMISCH ZIEKENHUIS GRONINGEN</legalName>
        <shortName>UNIVERSITAIR MEDISCH CENTRUM GRONINGEN</shortName>
        <address>
          <street>HANZEPLEIN 1</street>
          <city>Groningen</city>
          <postalCode>9713 GZ</postalCode>
          <country>NL</country>
          <postBox>30001</postBox>
          <url>http://www.umcg.nl</url>
          <geolocation>53.2213775,6.5773454</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471678</rcn>
              <nutsCode>NL115</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="718163.5" totalCost="0" source="corda" order="1" ecContribution="718163.5" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1906458</rcn>
        <id>999981634</id>
        <vatNumber>NL811383696B01</vatNumber>
        <legalName>WAGENINGEN UNIVERSITY</legalName>
        <shortName>WU</shortName>
        <address>
          <street>DROEVENDAALSESTEEG 4</street>
          <city>Wageningen</city>
          <postalCode>6708 PB</postalCode>
          <country>NL</country>
          <postBox>9101</postBox>
          <url>http://www.wageningenur.nl/nl.htm</url>
          <geolocation>51.9863279,5.6679366</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Veluwe</name>
              <rcn>391389313</rcn>
              <nutsCode>NL221</nutsCode>
              <parents>
                <region>
                  <name>Gelderland</name>
                  <rcn>391389352</rcn>
                  <nutsCode>NL22</nutsCode>
                  <parents>
                    <region>
                      <name>Oost-Nederland</name>
                      <rcn>391391784</rcn>
                      <nutsCode>NL2</nutsCode>
                      <parents>
                        <region>
                          <name>Netherlands</name>
                          <rcn>391547432</rcn>
                          <nutsCode>NL</nutsCode>
                          <euCode>NL</euCode>
                          <isoCode>NL</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Netherlands</name>
              <rcn>391547432</rcn>
              <nutsCode>NL</nutsCode>
              <euCode>NL</euCode>
              <isoCode>NL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="127500" totalCost="0" source="corda" order="3" ecContribution="127500" terminated="false" sme="true" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1966334</rcn>
        <id>951218473</id>
        <vatNumber>ESB62497276</vatNumber>
        <legalName>ASPHALION SL</legalName>
        <shortName>ASPHALION</shortName>
        <address>
          <street>CALLE TARRAGONA, NUMEROS 151-157, PLANTA 10, BLOQU</street>
          <city>Barcelona</city>
          <postalCode>08014</postalCode>
          <country>ES</country>
          <url>https://www.asphalion.com</url>
          <geolocation>41.3825596,2.1771353</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Barcelona</name>
              <rcn>242241601</rcn>
              <nutsCode>ES511</nutsCode>
              <parents>
                <region>
                  <name>Cataluña</name>
                  <rcn>242241640</rcn>
                  <nutsCode>ES51</nutsCode>
                  <parents>
                    <region>
                      <name>Este</name>
                      <rcn>242244136</rcn>
                      <nutsCode>ES5</nutsCode>
                      <parents>
                        <region>
                          <name>Spain</name>
                          <rcn>242387496</rcn>
                          <nutsCode>ES</nutsCode>
                          <euCode>ES</euCode>
                          <isoCode>ES</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Spain</name>
              <rcn>242387496</rcn>
              <nutsCode>ES</nutsCode>
              <euCode>ES</euCode>
              <isoCode>ES</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708776</rcn>
        <id>HORIZON_HORIZON-EIC-2024-TRANSITIONOPEN-01</id>
        <code>HORIZON-EIC-2024-TRANSITIONOPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Transition Open 2024</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode>/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-EIC</code>
        <title>HORIZON EIC Grants</title>
        <description>HORIZON EIC Grants</description>
        <displayCode>/HORIZON EIC Grants</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>